annual EBITDA:
$1.67B-$8.83B(-84.12%)Summary
- As of today (April 19, 2025), GILD annual EBITDA is $1.67 billion, with the most recent change of -$8.83 billion (-84.12%) on December 31, 2024.
- During the last 3 years, GILD annual EBITDA has fallen by -$9.66 billion (-85.29%).
- GILD annual EBITDA is now -92.89% below its all-time high of $23.45 billion, reached on December 31, 2015.
Performance
GILD EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$2.42B+$532.00M(+28.24%)Summary
- As of today (April 19, 2025), GILD quarterly EBITDA is $2.42 billion, with the most recent change of +$532.00 million (+28.24%) on December 31, 2024.
- Over the past year, GILD quarterly EBITDA has increased by +$532.00 million (+28.24%).
- GILD quarterly EBITDA is now -59.36% below its all-time high of $5.95 billion, reached on December 31, 2015.
Performance
GILD quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$3.74B-$177.00M(-4.52%)Summary
- As of today (April 19, 2025), GILD TTM EBITDA is $3.74 billion, with the most recent change of -$177.00 million (-4.52%) on December 31, 2024.
- Over the past year, GILD TTM EBITDA has dropped by -$177.00 million (-4.52%).
- GILD TTM EBITDA is now -84.04% below its all-time high of $23.45 billion, reached on December 31, 2015.
Performance
GILD TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
GILD EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -84.1% | +28.2% | -4.5% |
| 3 y3 years | -85.3% | +28.2% | -4.5% |
| 5 y5 years | -78.0% | +28.2% | -4.5% |
GILD EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -85.3% | at low | -25.3% | +168.2% | -65.0% | at low |
| 5 y | 5-year | -85.3% | at low | -42.6% | +168.2% | -69.6% | +108.0% |
| alltime | all time | -92.9% | +1672.7% | -59.4% | +168.2% | -84.0% | +3630.3% |
Gilead Sciences EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $1.67B(-84.1%) | $2.42B(+28.2%) | $3.74B(-4.5%) |
| Sep 2024 | - | $1.88B(-36.9%) | $3.92B(-25.6%) |
| Jun 2024 | - | $2.98B(-184.2%) | $5.27B(+10.1%) |
| Mar 2024 | - | -$3.54B(-236.6%) | $4.78B(-54.4%) |
| Dec 2023 | $10.50B(+18.6%) | $2.59B(-19.8%) | $10.50B(-1.8%) |
| Sep 2023 | - | $3.23B(+29.4%) | $10.69B(+0.5%) |
| Jun 2023 | - | $2.50B(+15.2%) | $10.64B(+2.2%) |
| Mar 2023 | - | $2.17B(-22.1%) | $10.41B(+17.6%) |
| Dec 2022 | $8.85B(-21.9%) | $2.79B(-12.6%) | $8.85B(+16.5%) |
| Sep 2022 | - | $3.19B(+40.4%) | $7.60B(-11.9%) |
| Jun 2022 | - | $2.27B(+271.5%) | $8.62B(-3.6%) |
| Mar 2022 | - | $611.00M(-60.1%) | $8.95B(-21.0%) |
| Dec 2021 | $11.33B(+174.1%) | $1.53B(-63.6%) | $11.33B(-7.9%) |
| Sep 2021 | - | $4.21B(+62.5%) | $12.30B(+29.4%) |
| Jun 2021 | - | $2.59B(-13.4%) | $9.51B(+109.7%) |
| Mar 2021 | - | $2.99B(+19.4%) | $4.53B(+9.7%) |
| Dec 2020 | $4.13B(-45.3%) | $2.51B(+77.1%) | $4.13B(+0.3%) |
| Sep 2020 | - | $1.42B(-159.4%) | $4.12B(+129.0%) |
| Jun 2020 | - | -$2.38B(-191.9%) | $1.80B(-75.0%) |
| Mar 2020 | - | $2.59B(+4.0%) | $7.19B(-4.9%) |
| Dec 2019 | $7.56B(-26.6%) | $2.49B(-375.9%) | $7.56B(+12.9%) |
| Sep 2019 | - | -$904.00M(-130.1%) | $6.70B(-38.5%) |
| Jun 2019 | - | $3.01B(+1.5%) | $10.89B(+2.8%) |
| Mar 2019 | - | $2.96B(+81.7%) | $10.59B(+2.7%) |
| Dec 2018 | $10.30B(-35.3%) | $1.63B(-50.4%) | $10.30B(-10.3%) |
| Sep 2018 | - | $3.29B(+21.3%) | $11.49B(-7.8%) |
| Jun 2018 | - | $2.71B(+1.0%) | $12.47B(-13.7%) |
| Mar 2018 | - | $2.68B(-5.0%) | $14.44B(-9.4%) |
| Dec 2017 | $15.93B(-17.1%) | $2.82B(-33.8%) | $15.93B(-9.4%) |
| Sep 2017 | - | $4.26B(-9.0%) | $17.59B(-3.1%) |
| Jun 2017 | - | $4.68B(+12.2%) | $18.15B(-1.2%) |
| Mar 2017 | - | $4.17B(-6.8%) | $18.38B(-4.4%) |
| Dec 2016 | $19.22B(-18.0%) | $4.48B(-7.1%) | $19.22B(-7.1%) |
| Sep 2016 | - | $4.82B(-1.9%) | $20.69B(-5.0%) |
| Jun 2016 | - | $4.91B(-2.1%) | $21.79B(-4.4%) |
| Mar 2016 | - | $5.01B(-15.6%) | $22.80B(-2.8%) |
| Dec 2015 | $23.45B(+43.7%) | $5.95B(+0.5%) | $23.45B(+5.9%) |
| Sep 2015 | - | $5.92B(-0.2%) | $22.14B(+10.9%) |
| Jun 2015 | - | $5.92B(+4.6%) | $19.96B(+6.7%) |
| Mar 2015 | - | $5.66B(+22.1%) | $18.71B(+14.7%) |
| Dec 2014 | $16.32B(+235.8%) | $4.63B(+23.8%) | $16.32B(+25.6%) |
| Sep 2014 | - | $3.74B(-19.9%) | $13.00B(+24.1%) |
| Jun 2014 | - | $4.67B(+43.1%) | $10.48B(+49.0%) |
| Mar 2014 | - | $3.27B(+148.5%) | $7.03B(+44.6%) |
| Dec 2013 | $4.86B(+14.3%) | $1.31B(+7.5%) | $4.86B(+2.8%) |
| Sep 2013 | - | $1.22B(-0.3%) | $4.73B(+2.4%) |
| Jun 2013 | - | $1.23B(+11.9%) | $4.62B(+2.2%) |
| Mar 2013 | - | $1.10B(-7.2%) | $4.51B(+6.2%) |
| Dec 2012 | $4.25B(+2.2%) | $1.18B(+6.3%) | $4.25B(+5.3%) |
| Sep 2012 | - | $1.11B(-1.2%) | $4.04B(+0.5%) |
| Jun 2012 | - | $1.13B(+35.2%) | $4.02B(+0.5%) |
| Mar 2012 | - | $832.27M(-14.0%) | $3.99B(-4.0%) |
| Dec 2011 | $4.16B(-3.0%) | $967.27M(-11.3%) | $4.16B(+1.2%) |
| Sep 2011 | - | $1.09B(-1.1%) | $4.11B(+0.7%) |
| Jun 2011 | - | $1.10B(+10.7%) | $4.08B(+0.8%) |
| Mar 2011 | - | $996.72M(+8.6%) | $4.05B(-5.6%) |
| Dec 2010 | $4.29B(+13.3%) | $917.66M(-13.7%) | $4.29B(-4.9%) |
| Sep 2010 | - | $1.06B(-0.6%) | $4.51B(+2.2%) |
| Jun 2010 | - | $1.07B(-13.5%) | $4.41B(+5.8%) |
| Mar 2010 | - | $1.24B(+8.4%) | $4.17B(+10.2%) |
| Dec 2009 | $3.78B(+30.8%) | $1.14B(+18.2%) | $3.78B(+8.6%) |
| Sep 2009 | - | $965.47M(+16.8%) | $3.48B(+8.2%) |
| Jun 2009 | - | $826.62M(-2.9%) | $3.22B(+5.6%) |
| Mar 2009 | - | $851.62M(+1.4%) | $3.05B(+4.5%) |
| Dec 2008 | $2.89B(+30.6%) | $839.67M(+19.6%) | $2.92B(+12.1%) |
| Sep 2008 | - | $702.35M(+6.9%) | $2.60B(+5.7%) |
| Jun 2008 | - | $657.02M(-8.8%) | $2.46B(+4.2%) |
| Mar 2008 | - | $720.38M(+37.5%) | $2.36B(+6.7%) |
| Dec 2007 | $2.22B | $523.95M(-6.9%) | $2.22B(+1.2%) |
| Sep 2007 | - | $562.56M(+0.9%) | $2.19B(+6.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2007 | - | $557.46M(-2.5%) | $2.05B(+9.6%) |
| Mar 2007 | - | $571.82M(+15.1%) | $1.87B(+11.2%) |
| Dec 2006 | $1.68B(+47.0%) | $496.99M(+17.0%) | $1.68B(+8.0%) |
| Sep 2006 | - | $424.79M(+12.4%) | $1.56B(+11.9%) |
| Jun 2006 | - | $377.90M(-1.3%) | $1.39B(+7.2%) |
| Mar 2006 | - | $382.89M(+3.0%) | $1.30B(+13.4%) |
| Dec 2005 | $1.14B(+75.6%) | $371.71M(+43.2%) | $1.14B(+21.7%) |
| Sep 2005 | - | $259.58M(-8.6%) | $940.55M(+10.5%) |
| Jun 2005 | - | $283.93M(+23.7%) | $850.86M(+16.4%) |
| Mar 2005 | - | $229.61M(+37.1%) | $731.14M(+12.2%) |
| Dec 2004 | $651.79M(+85.8%) | $167.43M(-1.4%) | $651.79M(+12.7%) |
| Sep 2004 | - | $169.89M(+3.5%) | $578.50M(+17.4%) |
| Jun 2004 | - | $164.21M(+9.3%) | $492.94M(+11.7%) |
| Mar 2004 | - | $150.27M(+59.6%) | $441.45M(+25.8%) |
| Dec 2003 | $350.78M(+267.6%) | $94.13M(+11.6%) | $350.78M(+19.6%) |
| Sep 2003 | - | $84.33M(-25.2%) | $293.38M(+18.0%) |
| Jun 2003 | - | $112.72M(+89.1%) | $248.72M(+56.8%) |
| Mar 2003 | - | $59.60M(+62.3%) | $158.62M(+66.2%) |
| Dec 2002 | $95.44M(-190.0%) | $36.73M(-7.4%) | $95.44M(+153.6%) |
| Sep 2002 | - | $39.66M(+75.3%) | $37.63M(-209.7%) |
| Jun 2002 | - | $22.63M(-731.2%) | -$34.31M(-60.7%) |
| Mar 2002 | - | -$3.58M(-83.0%) | -$87.23M(-17.7%) |
| Dec 2001 | -$106.00M(+163.0%) | -$21.08M(-34.7%) | -$106.00M(+5.7%) |
| Sep 2001 | - | -$32.27M(+6.6%) | -$100.25M(+16.3%) |
| Jun 2001 | - | -$30.29M(+35.5%) | -$86.20M(+47.4%) |
| Mar 2001 | - | -$22.36M(+45.8%) | -$58.47M(+55.2%) |
| Dec 2000 | -$40.31M(+3.1%) | -$15.33M(-15.9%) | -$37.67M(+247.4%) |
| Sep 2000 | - | -$18.23M(+614.7%) | -$10.84M(-32.3%) |
| Jun 2000 | - | -$2.55M(+63.7%) | -$16.01M(-29.7%) |
| Mar 2000 | - | -$1.56M(-113.6%) | -$22.77M(-34.5%) |
| Dec 1999 | -$39.10M(-39.9%) | $11.50M(-149.1%) | -$34.77M(-45.6%) |
| Sep 1999 | - | -$23.40M(+151.4%) | -$63.97M(+19.4%) |
| Jun 1999 | - | -$9.31M(-31.4%) | -$53.57M(-15.5%) |
| Mar 1999 | - | -$13.56M(-23.4%) | -$63.36M(+3.4%) |
| Dec 1998 | -$65.10M(+14.4%) | -$17.70M(+36.2%) | -$61.30M(-17.5%) |
| Sep 1998 | - | -$13.00M(-31.9%) | -$74.30M(-1.7%) |
| Jun 1998 | - | -$19.10M(+66.1%) | -$75.60M(+32.2%) |
| Mar 1998 | - | -$11.50M(-62.5%) | -$57.20M(+0.7%) |
| Dec 1997 | -$56.90M(+80.1%) | -$30.70M(+114.7%) | -$56.80M(+51.1%) |
| Sep 1997 | - | -$14.30M(+1942.9%) | -$37.60M(+121.2%) |
| Jun 1997 | - | -$700.00K(-93.7%) | -$17.00M(-44.1%) |
| Mar 1997 | - | -$11.10M(-3.5%) | -$30.40M(-3.5%) |
| Dec 1996 | -$31.60M(+9.7%) | -$11.50M(-282.5%) | -$31.50M(+57.5%) |
| Sep 1996 | - | $6.30M(-144.7%) | -$20.00M(-43.0%) |
| Jun 1996 | - | -$14.10M(+15.6%) | -$35.10M(+21.5%) |
| Mar 1996 | - | -$12.20M(+38.6%) | -$28.90M(-9.7%) |
| Dec 1995 | -$28.80M(-8.0%) | - | - |
| Sep 1995 | - | -$8.80M(+11.4%) | -$32.00M(+6.0%) |
| Jun 1995 | - | -$7.90M(-11.2%) | -$30.20M(+2.4%) |
| Mar 1995 | - | -$8.90M(+39.1%) | -$29.50M(+2.1%) |
| Mar 1995 | -$31.30M(+17.2%) | - | - |
| Dec 1994 | - | -$6.40M(-8.6%) | -$28.90M(-1.0%) |
| Sep 1994 | - | -$7.00M(-2.8%) | -$29.20M(+3.2%) |
| Jun 1994 | - | -$7.20M(-13.3%) | -$28.30M(+7.2%) |
| Mar 1994 | -$26.70M(+61.8%) | -$8.30M(+23.9%) | -$26.40M(+7.3%) |
| Dec 1993 | - | -$6.70M(+9.8%) | -$24.60M(+11.8%) |
| Sep 1993 | - | -$6.10M(+15.1%) | -$22.00M(+14.6%) |
| Jun 1993 | - | -$5.30M(-18.5%) | -$19.20M(+17.8%) |
| Mar 1993 | -$16.50M(+211.3%) | -$6.50M(+58.5%) | -$16.30M(-4.1%) |
| Dec 1992 | - | -$4.10M(+24.2%) | -$17.00M(+37.1%) |
| Sep 1992 | - | -$3.30M(+37.5%) | -$12.40M(+39.3%) |
| Jun 1992 | - | -$2.40M(-66.7%) | -$8.90M(+41.3%) |
| Mar 1992 | -$5.30M(+32.5%) | -$7.20M(-1540.0%) | -$6.30M(+57.5%) |
| Dec 1991 | - | $500.00K(+150.0%) | -$4.00M(-9.1%) |
| Sep 1991 | - | $200.00K(0.0%) | -$4.40M(-2.2%) |
| Jun 1991 | - | $200.00K(-104.1%) | -$4.50M(-2.2%) |
| Mar 1991 | -$4.00M | -$4.90M(-5000.0%) | -$4.60M(-1633.3%) |
| Dec 1990 | - | $100.00K(0.0%) | $300.00K(+50.0%) |
| Sep 1990 | - | $100.00K(0.0%) | $200.00K(+100.0%) |
| Jun 1990 | - | $100.00K | $100.00K |
FAQ
- What is Gilead Sciences annual EBITDA?
- What is the all time high annual EBITDA for Gilead Sciences?
- What is Gilead Sciences annual EBITDA year-on-year change?
- What is Gilead Sciences quarterly EBITDA?
- What is the all time high quarterly EBITDA for Gilead Sciences?
- What is Gilead Sciences quarterly EBITDA year-on-year change?
- What is Gilead Sciences TTM EBITDA?
- What is the all time high TTM EBITDA for Gilead Sciences?
- What is Gilead Sciences TTM EBITDA year-on-year change?
What is Gilead Sciences annual EBITDA?
The current annual EBITDA of GILD is $1.67B
What is the all time high annual EBITDA for Gilead Sciences?
Gilead Sciences all-time high annual EBITDA is $23.45B
What is Gilead Sciences annual EBITDA year-on-year change?
Over the past year, GILD annual EBITDA has changed by -$8.83B (-84.12%)
What is Gilead Sciences quarterly EBITDA?
The current quarterly EBITDA of GILD is $2.42B
What is the all time high quarterly EBITDA for Gilead Sciences?
Gilead Sciences all-time high quarterly EBITDA is $5.95B
What is Gilead Sciences quarterly EBITDA year-on-year change?
Over the past year, GILD quarterly EBITDA has changed by +$532.00M (+28.24%)
What is Gilead Sciences TTM EBITDA?
The current TTM EBITDA of GILD is $3.74B
What is the all time high TTM EBITDA for Gilead Sciences?
Gilead Sciences all-time high TTM EBITDA is $23.45B
What is Gilead Sciences TTM EBITDA year-on-year change?
Over the past year, GILD TTM EBITDA has changed by -$177.00M (-4.52%)